TNF and COVID-19: Anti-TNF users who did not have COVID-19 stopped taking the treatment for an average of 3 months (min 2–max 4 months) starting from March 2020, and the patients who had COVID-19 (p = 0.102) stopped taking the treatment for 1.5 months (min 1–max 2 months).